Nomura Micro Science (6254) Fundamentals 2026 — P/E 40.9x, Revenue Analysis | SniperIQ
Nomura Micro Science (6254) is a JP-listed Industrials company in Industrial - Machinery with a market capitalization of ¥157.0B, trading at ¥4100.00 on the JPX. This SniperIQ fundamentals page covers Nomura Micro Science's valuation (P/E 40.9x, P/B 3.9x), profitability (net margin 6.8%), revenue (¥56.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Nomura Micro Science's market cap?
Nomura Micro Science (6254) has a market capitalization of approximately ¥157.0B, trading at ¥4100.00 on the JPX. Market cap moves with the live share price.
What is Nomura Micro Science's P/E ratio?
Nomura Micro Science's trailing twelve-month P/E ratio is 40.9x, with a price-to-book (P/B) of 3.9x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Nomura Micro Science?
Nomura Micro Science runs a net profit margin of 6.8%, a gross margin of 22.6%, and an operating margin of 11.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Nomura Micro Science generate?
Nomura Micro Science reported revenue of ¥56.2B for fiscal year 2025, with net income of ¥3.8B and earnings per share (EPS) of 100.35. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Nomura Micro Science pay a dividend?
Nomura Micro Science offers a trailing dividend yield of about 2.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Nomura Micro Science financially healthy?
Nomura Micro Science carries a debt-to-equity ratio of 1.33x and a current ratio of 1.47x, with a market beta of 1.54. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Nomura Micro Science a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Nomura Micro Science (6254) the key facts are: market cap ¥157.0B, P/E 40.9x, revenue ¥56.2B, 52-week range 2331-5500. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track Nomura Micro Science's full fundamentals live
Get Nomura Micro Science's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.